Clinical Trial Update: Glofitamab Combined With CAR-T Therapy in R/R DLBCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing glofitamab in combination with CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma; the study is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CAR-T cell therapy
• Columvi (glofitamab)

Snippet

Sponsor: Ruijin Hospital | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING